SEC Filing Summary

Jessica Perl, SVP, General Counsel, and Corp Sec of Emergent BioSolutions Inc., was granted 104,282 restricted stock units (RSUs) on April 29, 2026. This grant, approved by the Compensation Committee and subject to stockholder approval of the Amended Stock Incentive Plan, vests in three annual installments starting from the anniversary of the approval date, provided continued service with the company. Each RSU represents the right to receive one share of common stock. Following this transaction, Ms. Perl owns 165,286 shares of common stock. The filing was made on May 1, 2026.